The first Karuna Therapeutics trade was made in Q3 2019.
Since then Steven Cohen bought shares five more times and sold shares on six occasions. The investor completely sold their stake between Q4 2023 and Q1 2024.
Avg closing price
Price range
Sold -64.6 Thousand shares
Q1 2024
Avg closing price
$317.26
Price range
$313.42
-
$329.83
Sold 81.4% shares (-283 Thousand shares)
Q4 2023
Avg closing price
$194.38
Price range
$161.01
-
$317.85
Increased shares by 657.1% (+302 Thousand shares)
Q3 2023
Avg closing price
$188.03
Price range
$164.66
-
$218.08
Sold 91.8% shares (-518 Thousand shares)
Q2 2023
Avg closing price
$214.25
Price range
$176.32
-
$240.22
Increased shares by 631.9% (+487 Thousand shares)
Q1 2023
Avg closing price
$191.25
Price range
$161.33
-
$204.36
Sold 71.3% shares (-191 Thousand shares)
Q4 2022
Avg closing price
$214.43
Price range
$191.53
-
$236.82
New holding (+268 Thousand shares)
Q3 2022
Avg closing price
$202.40
Price range
$123.79
-
$277.42
Sold -192 Thousand shares
Q2 2022
Avg closing price
$114.93
Price range
$93.97
-
$143.33
Increased shares by 106.0% (+98.7 Thousand shares)
Q1 2022